Hormonal
Testosterone replacement therapy in men with acquired hypogonadism significantly increases spinal and trabecular bone mineral density (BMD) and lean muscle mass while decreasing body fat percentage over 18 months.
If you are a man diagnosed with hypogonadism (low testosterone), testosterone replacement therapy (typically 100mg/week) can significantly increase your bone density and muscle mass while reducing body fat over 18 months. This treatment addresses the underlying hormonal deficiency, leading to measurable structural improvements in the body.
We conclude that testosterone administration in adult men with acquired hypogonadism increases bone density and lean muscle mass.
Why this rating
Randomized controlled trial design with a control group, though the treatment group had some attrition.
Source
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Laurence Katznelson et al. · The Journal of Clinical Endocrinology & Metabolism · 1996
DOI 10.1210/jcem.81.12.8954042
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →